Tiago Rodrigues

Dr. Tiago Rodrigues

Universidade Federal do ABC, Santo André, São Paulo, Brazil
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Biochemical Pharmacology
Verified
Journal Article
Closed access
Tiago RodriguesTiago Rodrigues
Tiago Rodrigues
Letícia Silva FerrazLetícia Silva Ferraz
Letícia Silva Ferraz

14 July 2011 in BMC Cancer
Verified
Journal Article
Open access
PDF file
FSFabiana A Serrano
Fabiana A Serrano
AMAlisson L Matsuo
Alisson L Matsuo
PMPriscila T Monteforte
Priscila T Monteforte
ABAlexandre Bechara
Alexandre Bechara
SSSoraya Smaili
Soraya Smaili
ERElaine Guadelupe Rodrigues
Elaine Guadelupe Rodrigues
Background: Systemic therapy for cancer metastatic lesions is difficult and generally renders a poor clinical response. Structural analogs of cisplatin, the most widely used synthetic metal complexes, show toxic side-effects and tumor cell resistance. Recently, palladium complexes with increased stability are being investigated to circumvent these limitations, and a biphosphinic cyclopalladated complex {Pd2[S(-)C2, N-dmpa]2(μ-dppe)Cl2} named C7a efficiently controls the subcutaneous development of B16F10-Nex2 murine melanoma in syngeneic mice. Presently, we investigated the melanoma cell killing mechanism induced by C7a, and extended preclinical studies.Methods: B16F10-Nex2 cells were treatedin vitrowith C7a in the presence/absence of DTT, and several parameters related to apoptosis induction were evaluated. Preclinical studies were performed, and mice were endovenously inoculated with B16F10-Nex2 cells, intraperitoneally treated with C7a, and lung metastatic nodules were counted. The cytotoxic effects and the respiratory metabolism were also determined in human tumor cell lines treatedin vitrowith C7a.Results: Cyclopalladated complex interacts with thiol groups on the mitochondrial membrane proteins, causes dissipation of the mitochondrial membrane potential, and induces Bax translocation from the cytosol to mitochondria, colocalizing with a mitochondrial tracker. C7a also induced an increase in cytosolic calcium concentration, mainly from intracellular compartments, and a significant decrease in the ATP levels. Activation of effector caspases, chromatin condensation and DNA degradation, suggested that C7a activates the apoptotic intrinsic pathway in murine melanoma cells. In the preclinical studies, the C7a complex protected against murine metastatic melanoma and induced death in several human tumor cell lineagesin vitro, including cisplatin-resistant ones. The mitochondria-dependent cell death was also induced by C7a in human tumor cells.Conclusions: The cyclopalladated C7a complex is an effective chemotherapeutic anticancer compound against primary and metastatic murine and human tumors, including cisplatin-resistant cells, inducing apoptotic cell death via the intrinsic pathway.

1 April 2015 in Toxicology
Verified
Journal Article
Closed access
PFPriscila A. de Faria
Priscila A. de Faria
FBFernanda Bettanin
Fernanda Bettanin
RCRodrigo L. O. R. Cunha
Rodrigo L. O. R. Cunha
EGEdgar Julian Paredes Gamero
Edgar Julian Paredes Gamero
Paula Homem-De-MelloPaula Homem-De-Mello
Paula Homem-De-Mello
Tiago RodriguesTiago Rodrigues
Tiago Rodrigues

1 June 2020 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
CCClaudia A. Costa
Claudia A. Costa
RLRayssa M. Lopes
Rayssa M. Lopes
Letícia Silva FerrazLetícia Silva Ferraz
Letícia Silva Ferraz
GEGabriela N.N. Esteves
Gabriela N.N. Esteves
JIJuliana F. Di Iorio
Juliana F. Di Iorio
Tiago RodriguesTiago Rodrigues
Tiago Rodrigues

6 June 2013 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
VMV W R Moraes
V W R Moraes
ACA C F Caires
A C F Caires
EGEdgar Julian Paredes Gamero
Edgar Julian Paredes Gamero
Tiago RodriguesTiago Rodrigues
Tiago Rodrigues
The advances in the treatment of chronic myeloid leukemia (CML) during the last years were also accompanied by the development of evading strategies by tumor cells, resulting in chemotherapy resistance in some patients. Patented organopalladium compounds derived from the reaction of N,N-dimethyl-1-phenethylamine (dmpa) with [1,2-ethanebis(diphenylphosphine)] (dppe) exhibited a potent antitumor activity in vivo and in vitro in melanoma cells. We showed here that the cyclopalladated derivative [Pd2(R(+))C2, N-dmpa)2(μ-dppe)Cl2], named compound 7b, was highly effective to promote cell death in the K562 human leukemia cells and its mechanisms of action were investigated. It was shown that compound 7b was able to promote exclusively apoptotic cell death in K562 cells associated to cytochrome c release and caspase 3 activation. This cytotoxic effect was not observed in normal peripheral mononuclear blood cells. The compound 7b-induced intrinsic apoptotic pathway was triggered by the protein thiol oxidation that resulted in the dissipation of the mitochondrial transmembrane potential. The preventive effect of the dithiothreitol on the compound 7b-induced cell death and all downstream events associated to apoptosis confirmed that death signal was elicited by the thiol oxidation. These findings contribute to the elucidation of the palladacycle 7b-induced cell death mechanism and present this compound as a promising drug in the CML antitumor chemotherapy.

1 August 2020 in Biochemical Pharmacology
Verified
Journal Article
Closed access
Letícia Silva FerrazLetícia Silva Ferraz
Letícia Silva Ferraz
RCRenata Torres da Costa
Renata Torres da Costa
CCCláudia Alves da Costa
Cláudia Alves da Costa
CRCésar Augusto João Ribeiro
César Augusto João Ribeiro
DADenise Costa Arruda
Denise Costa Arruda
Tiago RodriguesTiago Rodrigues
Tiago Rodrigues